137 related articles for article (PubMed ID: 791107)
1. Effects of doxycycline in actively purging cholera patients: a double-blind clinical trial.
Rahaman MM; Majid MA; Alam AKMJ ; Islam MR
Antimicrob Agents Chemother; 1976 Oct; 10(4):610-2. PubMed ID: 791107
[TBL] [Abstract][Full Text] [Related]
2. Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.
Rabbani GH; Islam MR; Butler T; Shahrier M; Alam K
Antimicrob Agents Chemother; 1989 Sep; 33(9):1447-50. PubMed ID: 2684006
[TBL] [Abstract][Full Text] [Related]
3. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139.
Khan WA; Bennish ML; Seas C; Khan EH; Ronan A; Dhar U; Busch W; Salam MA
Lancet; 1996 Aug; 348(9023):296-300. PubMed ID: 8709688
[TBL] [Abstract][Full Text] [Related]
4. Randomised double blind trial of single dose doxycycline for treating cholera in adults.
Alam AN; Alam NH; Ahmed T; Sack DA
BMJ; 1990 Jun; 300(6740):1619-21. PubMed ID: 2196962
[TBL] [Abstract][Full Text] [Related]
5. Comparative trial of tetracycline, chloramphenicol, and trimethoprim-sulphamethoxazole in eradication of Vibrio cholerae El Tor.
Gharagozloo RA; Naficy K; Mouin M; Nassirzadeh MH; Yalda R
Br Med J; 1970 Oct; 4(5730):281-2. PubMed ID: 4920226
[TBL] [Abstract][Full Text] [Related]
6. Single dose tetracycline in cholera.
Islam MR
Gut; 1987 Aug; 28(8):1029-32. PubMed ID: 3311904
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline in the treatment of cholera.
De S; Chaudhuri A; Dutta P; Dutta D; De SP; Pal SC
Bull World Health Organ; 1976; 54(2):177-9. PubMed ID: 1088099
[TBL] [Abstract][Full Text] [Related]
8. Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal.
Hossain MS; Salam MA; Rabbani GH; Kabir I; Biswas R; Mahalanabis D
J Health Popul Nutr; 2002 Mar; 20(1):18-25. PubMed ID: 12022154
[TBL] [Abstract][Full Text] [Related]
9. Single-dose doxycycline for cholera.
Sack DA; Islam S; Rabbani H; Islam A
Antimicrob Agents Chemother; 1978 Sep; 14(3):462-4. PubMed ID: 708024
[TBL] [Abstract][Full Text] [Related]
10. Controlled comparison of tetracycline and furazolidone in cholera.
Pierce NF; Banwell JG; Mitra RC; Caranasos GJ; Keimowitz RI; Thomas J; Mondal A
Br Med J; 1968 Aug; 3(5613):277-80. PubMed ID: 4873660
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children.
Roy SK; Islam A; Ali R; Islam KE; Khan RA; Ara SH; Saifuddin NM; Fuchs GJ
Trans R Soc Trop Med Hyg; 1998; 92(4):460-2. PubMed ID: 9850410
[TBL] [Abstract][Full Text] [Related]
12. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.
Khan WA; Begum M; Salam MA; Bardhan PK; Islam MR; Mahalanabis D
Trans R Soc Trop Med Hyg; 1995; 89(1):103-6. PubMed ID: 7747291
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.
Morris JG; Losonsky GE; Johnson JA; Tacket CO; Nataro JP; Panigrahi P; Levin MM
J Infect Dis; 1995 Apr; 171(4):903-8. PubMed ID: 7706818
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulphamethoxazole in the treatment of cholera. Comparison with tetracycline and chloramphenicol.
Pastore G; Rizzo G; Fera G; Schiraldi O
Chemotherapy; 1977; 23(2):121-8. PubMed ID: 832549
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae.
Rabbani GH; Butler T; Knight J; Sanyal SC; Alam K
J Infect Dis; 1987 May; 155(5):979-84. PubMed ID: 3549923
[TBL] [Abstract][Full Text] [Related]
16. Effect of chemotherapy on the duration of diarrhoea, and on vibrio excretion by cholera patients.
Francis TI; Lewis EA; Oyediran AB; Okubadejo OA; Montefiore D; Onyewotu II; Mohammed I; Ayoola EA; Vincent R
J Trop Med Hyg; 1971 Aug; 74(8):172-6. PubMed ID: 4936576
[No Abstract] [Full Text] [Related]
17. Clinical studies of the use of bacteriophage in the treatment of cholera.
Marcuk LM; Nikiforov VN; Scerbak JF; Levitov TA; Kotljarova RI; Naumsina MS; Davydov SU; Monsur KA; Rahman MA; Latif MA; Northrup RS; Cash RA; Hug I; Dey CR; Phillips RA
Bull World Health Organ; 1971; 45(1):77-83. PubMed ID: 4946956
[TBL] [Abstract][Full Text] [Related]
18. Study to determine duration of vibrio cholerae excretion in Malawians and to test efficacy of treatment.
Mkandawire AC
Cent Afr J Med; 1981 Jul; 27(7):138-42. PubMed ID: 7307069
[No Abstract] [Full Text] [Related]
19. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.
Bhattacharya SK; Bhattacharya MK; Dutta P; Dutta D; De SP; Sikdar SN; Maitra A; Dutta A; Pal SC
Antimicrob Agents Chemother; 1990 May; 34(5):939-40. PubMed ID: 2193628
[TBL] [Abstract][Full Text] [Related]
20. Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania.
Mhalu FS; Mmari PW; Ijumba J
Lancet; 1979 Feb; 1(8112):345-7. PubMed ID: 85001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
